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There is a close relationship between cognitive performance and nutritional status, but the 
mechanisms underlying this relationship are not well understood.  
The hormone, ghrelin, which is released during food restriction, triggers adaptive responses 
to improve learning and memory by increasing the formation of new neurones in the adult 
brain. 
The birth of new neurones (neurogenesis) from neural stem cells in the adult mammalian brain 
is an important process involved in protecting against the age-related decline in cognitive 
function.  
Activation of the hippocampal ghrelin-receptor may be a viable therapeutic approach to 







   
 
   
 
Glossary 
Acyl-ghrelin (AG): A Form of ghrelin that has been acylated by GOAT, which enables it to 
bind to GHS-R1a.  
Acyl-protein thioesterase 1 (APT1): An endogenous enzyme known to de-acylate acyl-
ghrelin 
Allosteric mechanism:  Regulation of a protein or receptor independent of its active site.  
 
Brain derived neurotrophic factor (BDNF):  A growth factor in the brain, involved in cell 
proliferation, survival, learning and memory.  
 
Bromodeoxyuridine (BrdU):  A synthetic thymidine analogue, incorporated into DNA during 
replication. It can be used as a marker of proliferation during a specific timeframe.  
Butyrylcholinesterase: An enzyme that hydrolyses many different choline-based esters, but 
can also de-acylate acyl-ghrelin, (AG) to form unacylated ghrelin (UAG). Endogenous 
esterase enzyme present in the plasma known to de-acylate acyl-ghrelin. 
Caloric restriction (CR): A reduction of food intake (typically 30% less) in the absence of 
malnutrition.  
 
Calorie Restriction mimetics: endogenous or exogenous factors that mimic the effects of 
CR 
cAMP response element binding protein (CREB): A transcription factor regulating BDNF 
expression and important in neuronal plasticity and memory.  
Dentate gyrus (DG): A sub-region of the hippocampus where neurogenesis occurs.  
 
Ghrelin-O-Acyl transferase (GOAT): a member of the membrane bound O-Acyl transferase 
(MBOAT) family, the only enzyme known to acylate ghrelin.  
 
GluA1-containing  α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPAR) 
receptors:  Glutamate receptor and ion channels responsible for fast excitatory synaptic 
transmission.  Important for synaptic plasticity and long-term potentiation (LTP). 
 
   
 
   
 
Growth hormone secretagogue receptor (GHSR): A G-protein-coupled receptor (GPCR) 
also known as the ghrelin receptor. It is the only known receptor for acyl-ghrelin. 
 
GHSR-eGFP mice: genetically mutated mice that co-express green fluorescent protein (GFP) 
with the Growth Hormone Secretagogue Receptor (GHS-R) gene 
 
Heterodimers: A protein complex, consisting of two different proteins.  
 
Hormesis: A bi-phasic dose-response to a drug or intervention, in which a low dose produces 
a beneficial effect and a high dose produces a harmful effect. 
 
Long-term potentiation (LTP): An important process in memory formation, resulting 
in a long-term increase in the strength of electrical activity or transmission 
between two neurones.    
 
Neural stem progenitor cells (NSPCs): Multipotent stem cells that reside in the brain with 
the capacity to differentiate into any neural cell type. 
 
Novel object recognition (NOR): Behaviour test of cognitive function that requires 
recognising novel from familiar objects. This is a hippocampal-dependent task.  
 
Passive avoidance learning (PAL): Behaviour test that evaluate memory and learning in 
rodents with neurological disorders. The rodents learn to avoid an environment in which an 
aversive stimulus was previously delivered. 
 
Pattern separation: The ability to distinguish similar inputs into separate discrete outputs. 
 
SAMP8 mice: a naturally occurring mouse model of accelerated ageing with symptoms of 
cognitive decline.  
 
Spontaneous location recognition (SLR) task: Behavioural test of cognitive function that 
requires the ability to discriminate similar but distinct spatial contexts. This is a hippocampal 
neurogenesis dependent task.  
 
Synaptic plasticity: The ability of a synapse to respond to signals, thereby enhancing or 
decreasing the strength of connection.  Thought to be an important mechanism in learning 
and memory. 
   
 
   
 
 
Un-acylated ghrelin (UAG): The un-acylated form of ghrelin (also known as des-acyl ghrelin 
(DAG)).  Initially thought to be the inactive as it does not activate the ghrelin 
receptor.  Subsequent research suggests it has physiological effects independent of GHSR.  
 
5xFAD mice: a transgenic mouse model of Alzheimer’s Disease (AD) expressing mutant 
versions of human amyloid precursor protein (APP) (Swedish (K670N/M671L), Florida 





   
 
   
 
Abstract 
There is a close relationship between cognition and nutritional status, however, the 
mechanisms underlying this relationship require elucidation. The stomach hormone, ghrelin, 
which is released during food restriction, provides a link between circulating energy state and 
adaptive brain function. The maintenance of such homeostatic systems is essential for an 
organism to thrive and survive, and accumulating evidence points to ghrelin being key in 
promoting adult hippocampal neurogenesis and memory. Aberrant neurogenesis is linked to 
cognitive decline in ageing and neurodegeneration. Therefore, identifying endogenous 
metabolic factors that regulate new adult-born neurone formation is an important objective in 
understanding the link between nutritional status and CNS function. Here, we review current 
developments in our understanding of ghrelin’s role in regulating neurogenesis and memory 
function.  
   
 
   
 
Ghrelin 
The gut-derived hormone, ghrelin, was identified in 1999 as the natural ligand of the growth 
hormone secretagogue receptor 1a (GHS-R1a) that stimulates the release of growth hormone 
(GH) from the pituitary gland1. An early discovery was its ability to stimulate feeding2 resulting 
in the ‘hunger hormone’ name-tag. Ghrelin has subsequently been found to have numerous 
functions, including regulating gastric acid secretion and motility3, pancreatic cell proliferation 
and apoptosis4, sleep5, and cardiovascular function6. More recently, ghrelin has been linked 
to central nervous system (CNS) function, including protecting neurones7,8, regulating mood9 
and promoting neural plasticity via adult hippocampal neurogenesis (AHN)10–12.  
 
Ghrelin is predominantly produced by oxyntic cells of the stomach (as illustrated in figure 1), 
with lower amounts generated in the pancreas13, kidney14 and placenta15. There are reports 
of low-level ghrelin mRNA and peptide expression in the hypothalamus16, however 
subsequent studies unequivocally demonstrate that ghrelin is not produced in the brain17,18. 
Thus, ghrelin in the CNS derives from a peripheral source, and is consistent with the ability of 
ghrelin to cross the blood-brain barrier (BBB) in a metabolic state-dependent manner19,20 and 
bind its receptor in the brain21,22.   
 
Human ghrelin, encoded by the gene, GHRL, located on chromosome 3p25-26, generates the 
pre-proghrelin peptide that is enzymatically processed to a mature 28 amino acid peptide23. 
The native peptide, unacylated-ghrelin (UAG or des-acyl ghrelin), undergoes enzymatic 
modification in the endoplasmic reticulum by ghrelin-O-acyltransferase (GOAT) to generate 
acyl-ghrelin24,25. This involves the addition of a medium chain fatty acid (generally octanoic 
acid) at Serine residue 3 (Ser3), which is essential for it to bind and activate GHS-R1a 
signalling.  Notably, GOAT expression has been observed in the hippocampus where it is able 
to acylate ghrelin locally26. Acyl-ghrelin can also undergo de-acylation into UAG, mediated by 
acyl-protein thioesterase 1 (APT1)27 or butyrylcholinesterase28 to regulate its activity. The 
expression of APT1 in the brain has not been characterized, however, butyrylcholinesterase 
   
 
   
 
is expressed in the hippocampus29. As both acyl-ghrelin and UAG can cross the BBB21, it is 
therefore possible that both peptides undergo enzymatic conversion within the hippocampus 
in a cell specific manner. Whilst a receptor for UAG has not been identified, it has been shown 
to induce genome-wide expression changes in GHS-R1a knock-out mice30, suggesting the 
existence of an unknown UAG receptor.  
 
Figure 1. Summary of ghrelin production from the stomach.  
 
GHS-R1a is a 366 aa, seven transmembrane domain, G-protein coupled receptor (GPCR)31. 
It belongs to the rhodopsin family of GPCRs, primarily interacting with Gαq/11, with activation 
leading to the PLCβ/IP3 signalling cascade. A splice isoform of the receptor, termed GHS-R1b, 
is a truncated 289 aa form with only five transmembrane domains that lacks intracellular 
signalling ability32. GHS-R is expressed in several peripheral tissues, including the pancreas, 
lungs, myocardium, liver, intestine and adipose tissue33. Expression in the brain is restricted 
to several specific regions, including the hypothalamus, cortex, midbrain (including the 
substantia nigra), pons and medulla oblongata34,35. Most notably, GHS-R is highly expressed 
in the adult hippocampus, with initial reports of GHS-R1a mRNA expression33,36 subsequently 
confirmed at the protein level34. More specifically, the use of genetically modified GHSR-eGFP 
reporter mice demonstrated that GHS-R is most highly expressed in the dentate gyrus (DG) 
of the hippocampus11,35. This pattern of receptor localisation is thought to contribute to the 
regulation of a diverse array of ghrelin-related behaviours, including anxiety, stress-response, 
feeding, reward and learning and memory37. These behaviours are thought to involve distinct 
circuits, however where circuitry may overlap (i.e. signalling stress- and learning-related 
stimuli via hippocampal circuits), distinct signalling may be partially mediated by the formation 
of GHS-R1a dimers with other GPCRs. For example, GHS-R forms a complex with the 
dopamine receptor subtype 1 (D1R), which enhanced dopamine signalling in-vitro38.  
Interestingly, this led to a switch in the G-protein coupled to the receptor from Gαq to Gαi/o, 
suggesting that ghrelin is able to selectively enhance dopamine signalling in cells co-
   
 
   
 
expressing these proteins. However, dimerization is thought to occur in the absence of ghrelin, 
indicating allosteric regulatory processes39 (figure 2). GHS-R1a has also been shown to 
modulate serotonin signalling via dimerization with 5-HT2C receptors40,41 and oxytocin 
receptors42, whilst GHS-R1b forms heterodimers with GHS-R1a to diminish cell surface 
expression32,43. 
 
Figure 2. Putative GHS-R1a signaling pathways. 
 
To add further complexity, GHS-R1a exhibits high constitutive activity, at least in-vitro44–46. 
One potential explanation for this phenomenon is to attune a high signalling set-point to 
maintain energy state, necessary for survival47. Indeed, emerging evidence suggests ghrelin 
plays a role in survival, with increased levels of circulating ghrelin during energy insufficiency 
acting in a homeostatic manner to defend against hypoglycaemia (for review see Mani & 
Zigman48). For example, GOAT-/- mice, which lack acyl-ghrelin, show a marked increase in 
hypoglycaemia induced mortality when exposed to a prolonged 48h fast49. Alongside the 
glycaemic adaptations induced by acyl-ghrelin during energy deficit, it regulates important 
behavioural and physiological adaptations, beyond the stimulation of hunger, that may also 
play convergent roles in survival. These adaptive responses to energy deficit involve learning 
and memory11, neuroprotection8 and mood9,50, suggesting that acyl-ghrelin is a key metabolic 
hormone linking nutritional state to improvements in CNS function. Here, we focus on the 
evidence for ghrelin-mediated action at a key learning brain region, the hippocampus. In 
particular, we discuss the most recent developments in our understanding of ghrelin’s role in 
regulating the generation of new adult-born hippocampal neurones. 
The Hippocampus  
The hippocampus (figure 3), named from the Greek “Hippokampos” due to its structural 
resemblance to the Seahorse, is a major component of the limbic system that is essential to 
learning and memory. Studies investigating the role of the hippocampus in learning and 
   
 
   
 
memory were conducted on patients by William Scoville and Brenda Milner in 195751. One 
patient, suffering from an incurable form of epilepsy, underwent temporal lobectomy that 
successfully reduced seizures but resulted in profound global amnesia. The memory 
dysfunction was due to the removal of a large part of the hippocampal formation and the 
surrounding cortical region. Indeed, subsequent studies in model organisms revealed the 
essential nature of the hippocampus to episodic memory52. This memory system is essential 
for processing autobiographical memories, remembering the ‘what, where and when’ of 
events, thus providing spatial and contextual information for an organism to make important 
decisions relating to health and survival.   
 
Ghrelin mediated hippocampal memory 
Since 2002, accumulating evidence has indicated ghrelin’s involvement in hippocampal 
memory formation in various animal models (table 1). Initial investigations showed that a 
single administration of acyl-ghrelin either intracerebrovascular (i.c.v)53 or intra-hippocampal 
(i.h)54 promoted memory retention in rats, suggesting a consolidating effect on episodic 
memory. Later experiments revealed that acyl-ghrelin, when administered peripherally, 
enhanced hippocampal dendritic-spine synapse formation, increased long-term potentiation 
(LTP) - a physiological correlate of memory – and improved spatial memory22. Moreover, 
ghrelin knockout mice displayed reduced CA1 spine synapses and impaired spatial memory 
performance in the novel object recognition (NOR) task, which was rapidly recovered by 
peripheral treatment with acyl-ghrelin22. Electrophysiological analysis demonstrated that intra-
hippocampal administration of acyl-ghrelin enhanced the excitability of the hippocampus, 
thereby facilitating the induction of LTP and improved memory in rats55,56. Moreover, 
i.c.v injections of acyl-ghrelin for two weeks promoted hippocampal LTP and memory retention 
while ameliorating synaptic plasticity in a rat model of Alzheimer’s Disease (AD)57. This is 
consistent with the PI3K-dependent enhancement in LTP following intra-hippocampal 
injection of acyl-ghrelin58. Subsequent molecular analysis showed that the non-peptidyl GHS-
   
 
   
 
R1a agonist, MK-0677, enhanced synaptic delivery of GluA1-containing AMPA receptors, 
consequently increasing excitatory synaptic-transmission and plasticity59. Furthermore, acyl-
ghrelin upregulated expression of the phospho-GluN2B60 and the NR2B61 subunit of the 
NMDA receptor to enhance release of the excitatory neurotransmitter, glutamate61. Kern et al. 
(2015) showed that GHS-R1a forms a heterodimer with the dopamine receptor DRD1 in a 
complex with Gαq ex-vivo. To investigate this in vivo, mice treated with a DRD1 agonist into 
the DG showed enhanced hippocampal working memory, which was blocked by co-infusion 
of a GHS-R1a antagonist39. These tests indicate that DRD1 regulated behaviours depend on 
interactions between DRD1 and GHS-R1a in the DG. 
There are several lines of evidence to support a role for acyl-ghrelin in protecting neurones, 
which may ultimately support improvements in cognitive function. Firstly, acyl-ghrelin rescued 
deficits in spatial memory in streptozotocin-induced diabetic rats62. More specifically, acyl-
ghrelin increased cAMP response element binding protein (CREB) expression and led to the 
activation of the extracellular signal-regulated kinase 1/2 (ERK1/2) pathway and the promotion 
of brain derived neurotrophic factor (BDNF) expression in the hippocampus. Moreover, acyl-
ghrelin treatment of intrahippocampal amyloid-β injected mice, that mimic aspects of AD, 
rescued memory deficits63,64, decreased neuroinflammation64  and prevented the amyloid-β 
induced suppression of hippocampal LTP64. Similarly, in amyloid-β injected rats treated with 
acyl-ghrelin there was a reduction in amyloid-β plaque deposition and attenuation of memory 
impairments due to increased AMP-activated protein kinase (AMPK) and glycogen synthase 
kinase (GSK) phosphorylation, and decreased tau phosphorylation65. In a transgenic 5xFAD 
mouse model of AD, neuronal cell loss was prevented in the hippocampus of mice treated 
with acyl-ghrelin66. Notably, in the senescent SAMP8 mice, acyl-ghrelin increased baseline 
cognitive performance, suggesting that ghrelin signalling may preserve cognitive function in 
ageing22. Collectively, these data highlight an important role for ghrelin in hippocampal 
function under normal and disease conditions.  
   
 
   
 
Table 1. Summary of studies on ghrelin and hippocampal function 
Adult hippocampal neurogenesis (AHN)  
The process of AHN - as depicted in figure 3 – is an ongoing form of brain plasticity that 
combines expansion of the neural stem cell pool (to maintain the population) and 
differentiation, maturation and functional integration of these newly formed neural cells. In 
1962, Altman et al. provided the first evidence of newly formed neurones in the postnatal rat 
hippocampus67, termed adult hippocampal neurogenesis (AHN). Since then, the use of 
bromodeoxyuridine (BrdU), a synthetic analogue of thymidine which labels proliferating cells, 
has greatly facilitated studies on neurogenesis in model organisms. From the 1990s, 
researchers studying AHN have demonstrated the existence of new adult-born neurones in 
the SGZ of the human DG68,69 (see Box 1). Notably, these nerve cells show temporal 
functional specificity to separate highly similar components of memories into distinct memory 
representations that are unique and less easily confused. This function, termed ‘pattern 
separation’, is dependent on a reduced threshold for action potential firing when new adult-
born neurones are 4-6 weeks of age70. A series of elegant loss-of-function71 and gain-of-
function72 studies in mice confirmed the essential role of new adult-born neurones to pattern 
separation-dependent memory in mice. In addition, recent studies suggest a spatial functional 
specificity to neurogenesis, with new adult-born neurones in the rostral pole of the DG being 
important for episodic memory processing, whilst AHN in the caudal DG is linked with 
processing anxiety and stress-related memory73.   
 
Figure 3. Stages of adult hippocampal neurogenesis (AHN). 
 
The number of new adult-born neurones is regulated by several extrinsic factors. For example, 
aerobic exercise74 and environmental enrichment75 were shown to increase cell proliferation 
and survival of new adult born neurones, respectively, in rodents. Conversely, stress76 and 
ageing77 negatively impact neurogenesis, demonstrating the remarkable plasticity of the 
process to factors that lay outside of the brain. Notably, alternate day feeding78 was shown to 
   
 
   
 
increase the survival of new adult born cells in the adult DG, suggesting that factors 
responding to reduced calorie intake may regulate the hippocampal neurogenic niche. Here, 
we look at the impact of calorie restriction on hippocampal function and neurogenesis.  
 
 
Box 1: Controversy over human AHN? Several studies have confirmed the generation and important 
function of new adult-born mature neurones in the adult rodent hippocampus to spatial memory 
performance71,72. However, technical limitations have resulted in some contradictory studies 
investigating the existence of AHN in humans (for review see Kempermann 201879). (i.e prohibited use 
of the carcinogen, BrdU). For example, a recent study failed to detect AHN in aged human brain80. The 
field has been hampered by the limited collection and inconsistent preservation of post-mortem human 
brain tissue. However, an increasing number of studies demonstrate that post-mortem human tissue, 
collected with short post-mortem interval and appropriate fixation procedures, reveal the existence of 
new adult-born neurones within the DG. Recently, Boldrini et al.81 showed that AHN occurred in humans 
in the eighth decade of life, despite a decline in the quiescent stem cell pool, angiogenesis and 
neuroplasticity. Moreover, Moreno-Jiménez et al.82 described an improved protocol for the identification 
of new adult-born neurones in the human hippocampus and confirmed their presence in aged human 
hippocampus which progressively decreased in AD patients. These studies demonstrate that the AHN 
paradigm exists in humans and that it is modulated by environmental factors (i.e age, disease), as 
observed in rodent studies. These findings suggest that AHN may be modulated to prevent cognitive 




Benefits of CR on brain function and adult hippocampal neurogenesis 
Calorie restriction, defined as a reduction in food intake without incurring malnutrition83, 
increases lifespan and protects against obesity and cardiovascular disease (for review see Di 
Francesco et al.84). In addition, calorie restriction  benefits the brain by preventing cognitive 
decline85 and ameliorating neurodegeneration86,87 in rodent models of disease. Remarkably, 
calorie restriction reduces brain atrophy in monkeys83,88 and improves verbal memory scores 
in humans89. Delineating the molecular pathways underlying the beneficial effects of calorie 
restriction remains an important objective. Currently, these mechanisms are not fully 
understood, however, calorie restriction is known to increase the level of BDNF in the 
hippocampus of adult mice90. BDNF is crucial for the survival of neurones during development 
and for improving memory function91. More recently, calorie restriction was shown to induce 
hippocampal CREB in mice92. CREB regulates Sirtuin1 (SIRT1), a NAD+-dependent histone 
   
 
   
 
deacetylase that has a key role in neuronal plasticity and memory. In addition, calorie 
restriction (or the pharmacological activation of SIRT1) promoted SIRT1 activity in the 
hippocampus leading to preserved memory functions, delayed synaptic loss and attenuated 
onset of neurodegeneration87. While these studies show that calorie restriction can affect the 
molecular machinery of hippocampal cells involved in learning and memory, it does not 
address how these neurones sense nutritional state during calorie restriction. Moreover, the 
impact of these calorie restriction paradigms on hippocampal neurogenesis were not 
addressed, however, an increasing number of studies are starting to examine this relationship 
in more detail. For example, mice exposed to a very low calorie/low protein fasting mimicking 
diet had increased numbers of new immature DG neurones and improved cognitive 
performance93. 
Given that circulating acyl-ghrelin is increased during calorie restriction, we have previously 
investigated circulating acyl-ghrelin as a key metabolic hormone linking nutritional state with 
hippocampal neurogenesis and memory11. To determine whether calorie restriction promotes 
the generation of new mature adult-born hippocampal neurones and whether acyl-ghrelin 
signalling is required for this effect we exposed adult wild-type and GHS-R-null mice to a 30% 
reduction in food intake for two-weeks. Quantification of AHN revealed that two-weeks of 
calorie restriction led to a significant 52% increase in the number of new adult-born neurones 
specifically in the rostral DG of wild-type mice compared to ad-libitum fed wild-type mice. In 
this study, the caudal DG did not respond to the calorie restriction stimulus, suggesting that 
calorie restriction may be particularly relevant to rostral DG circuits underlying learning and 
memory. Notably, there was no increased AHN in GHS-R-null mice in either rostral or caudal 
pole, demonstrating that the beneficial effect of calorie restriction on AHN was mediated by 
GHS-R. In addition, the increase in new adult-born neurone number seemingly contributed to 
enhanced remote contextual fear conditioning in the calorie restricted wild-type mice11. 
However, their precise contribution needs to be further examined under conditions that place 
greater emphasis on pattern-separation performance. Nonetheless, these findings confirm the 
essential role of GHS-R in mediating the beneficial effects of calorie restriction on enhancing 
   
 
   
 
AHN. In support of this, a 3-month every-other-day feeding protocol increased the survival of 
new adult-born cells in the DG in wild-type but not ghrelin-ko mice94, suggesting that ghrelin 
signalling is important for the survival of new hippocampal cells. Collectively, these studies 
highlight that acyl-ghrelin is a critical metabolic hormone linking peripheral nutritional state to 
hippocampal neurogenesis and cognitive performance. We speculate that acyl-ghrelin 
agonists represent putative calorie restriction mimetics (see Box 2) 
 
Acyl-ghrelin treatment increases adult hippocampal neurogenesis  
As ghrelin is seemingly unique in its ability to communicate peripheral energy status to the 
brain via the activation of Neuropeptide Y (NPY) and Agouti-related protein (AGRP)-
dependent pathways, it is not unreasonable to suggest it plays an important role in mediating 
the beneficial effects of calorie restriction. Here, we discuss evidence for exogenous acyl-
ghrelin regulating AHN. Johansson et al. initially described the proliferative effect of ghrelin on 
adult rat hippocampal progenitor cells95. Subsequently, experiments in mice showed that daily 
intraperitoneal injection (IP) of acyl-ghrelin at supra-physiological doses (80 µg/kg) for 8 days 
increased the number of newly generated cells, labelled by BrdU, in the hippocampus96.  We 
later examined the longer-term effects of elevated acyl-ghrelin within the physiological range, 
using doses that mimic 24-hour fasting (10 µg/kg/day IP for 14 days)10. The total number of 
both immature neurones (Dcx+) and new adult-born neurones (BrdU+/NeuN+) were 
significantly increased in the DG after acyl-ghrelin treatment. The increase in AHN resulted in 
enhanced performance in the spontaneous location recognition (SLR) task, a neurogenesis 
dependent pattern separation-dependent test97. Notably, the behavioural test took place one 
week after the final injection of acyl-ghrelin, suggesting that it had a long-term effect to support 
memory. These findings are consistent with other studies reporting ghrelin-mediated 
increases in AHN12,98,99. 
To further examine the mechanisms of ghrelin on AHN, we increased acyl-ghrelin levels in 
adult GHSR-eGFP mice, either indirectly via an overnight fast, directly via IP injection (1mg/kg) 
or a combination of both overnight fast and acyl-ghrelin injection. Here, all three treatment 
   
 
   
 
paradigms induced the expression of the immediate early gene, early growth response-1 (Egr-
1) in DG neurones11. Egr-1 expression in mature DG neurones is an important gene involved 
in the selection, maturation and functional integration of new-born neurones into the DG 
network100. However, hippocampal cell proliferation was unchanged and is consistent with 
previous studies investigating the impact of calorie restriction on hippocampal cell 
proliferation78,94.    
It is likely that ghrelin supports AHN via several distinct pathways including via stimulation of 
growth hormone (GH)101 and consequent insulin growth factor-1, both of which can enter the 
brain to influence cognition and neurogenesis102.  However, in spontaneous dwarf rats, which 
lack circulating GH, ghrelin’s ability to enhance AHN and cognitive performance remained 
intact, suggesting that it can promote AHN independently from the somatotropic axis103. 
Additionally, ghrelin may modulate the neurogenic niche via extra-hippocampal neural-
circuitry. For example, GHS-R1a in the entorhinal cortex is activated by acyl-ghrelin and 
calorie restriction11, and promotes AHN104. Furthermore, vagal afferents, which express GHS-
R1a that regulate ghrelin-mediated feeding105, also support hippocampal BDNF expression 
and neurogenesis106. Other mechanisms, such as the phenomenon of ligand-independent 
GHS-R signalling39, have not been studied in the context of neurogenesis. Collectively, current 
data suggests that physiological levels of acyl-ghrelin increase AHN by promoting neurone 
differentiation, maturation and survival in the neurogenic niche of the DG. Further studies are 
necessary to examine the DG-specific, GHS-R1a-dependent and ghrelin-independent GHS-
R1a effects on AHN. 
 
Acyl-ghrelin enhances AHN in neurodegenerative disease models.  
Alzheimer’s disease (AD) is an age-related neurodegenerative disorder characterized by 
progressive neurone loss and deterioration of cognitive function. Hippocampal neurogenesis 
is impaired in AD and is thought to contribute to cognitive decline. The 5xFAD transgenic 
mouse model of AD exhibit impaired AHN and cognition coupled with increased hippocampal 
Aβ deposits. Choi et al.107 used this model to demonstrate that aerobic exercise reduced Aβ 
   
 
   
 
levels, promoted AHN and improved learning and memory performance. Mimicking the 
beneficial effects of exercise using genetic and pharmacological tools also promoted AHN and 
cognition, albeit without reducing Aβ levels. Notably, they show that suppressing AHN 
increased hippocampal neurone loss in 5xFAD but not wild-type mice. These data suggest 
that AHN plays a fundamental role in the memory deficit and neurodegeneration observed in 
this model of AD. Notably, acyl-ghrelin treatment (i.p) of 5xFAD mice, at a dose of 80 µg/kg 
every two days for 30 days, increased the number of cells expressing markers of immature 
neurones (Dcx and calretinin) without affecting Aβ levels66. These data suggest that elevating 
peripheral acyl-ghrelin is sufficient to enhance neurogenesis in this model of AD. In addition, 
as neurogenic deficits are associated with several neurodegenerative diseases such as 
Parkinson’s disease and dementia with Lewy bodies, it has been suggested that increasing 
AHN in these conditions may ameliorate the progression in cognitive decline or even restore 
cognition.  Further studies are warranted to determine whether acyl-ghrelin can promote the 
generation of new mature adult-born neurones to rescue learning and memory deficits in 
models of neurodegeneration. 
 
 
Box 2. Calorie restriction mimetics – a promising option to treat disease? A primary obstacle to 
benefiting from the myriad effects of calorie restriction is the need to adhere to diets that limit the 
intake of food. Furthermore, individuals diagnosed with chronic age-related neurodegenerative 
conditions, such as Alzheimer’s and Parkinson’s disease, often report weight loss and reduced appetite, 
suggesting impaired energy balance pathways that may not fully benefit from calorie restriction. 
Considerable effort is on-going to develop calorie restriction mimetics (CRMs), defined as drugs or 
compounds that mimic the beneficial effects of calorie restriction108. Indeed, a similar approach is 
ongoing to identify exercise-mimetics107,109. We suggest acyl-ghrelin mimetics as putative CRMs to 
enhance cognition. Recent findings identify MK-0677, a synthetic GHS-R agonist that crosses the BBB, 
as a potential therapeutic cognitive enhancer as it promoted the accumulation of α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid (AMPA) receptor on excitatory hippocampal synapses and improved 
long term potentiation (LTP)59. Moreover, Jeong et al.110 showed that MK-0677 ameliorated Aβ 
deposition, neuroinflammation, and neurodegeneration in the 5xFAD mouse model of AD. In the 
APPSwDI mouse model of AD the GHS-R agonist, LY444711, improved spatial memory 
performance111. Other GHS-R agonists also improved memory and cognition, in particular, 
GSK894490A and CP-464709-18, crossed the BBB and promoted object recognition and spatial 
memory112. Notably, the synthetic peptide GHS-R agonist, hexarelin, promoted the survival of new adult 
born hippocampal cells113, suggesting that it may promote AHN. These results provide compelling 
evidence that synthetic GHS-R agonists may form a novel class of CRMs. Further studies are required 
   
 
   
 
to determine the effect of these putative CRMs on AHN and cognition, as well as possible negative 
effects on metabolism, in models of ageing and disease. 
 
 
Characterisation of GHS-R expression in the brain using a GHSR-eGFP reporter mouse34, 
identified GHSR-eGFP+/NeuN+ immunoreactive cells in the mature DG neurone granule cell 
population11. These were in apposition to both type I (nestin+) and type II (Sox2+) NSPCs. 
GHSR-eGFP immunoreactivity was not detected in NSPCs. Furthermore, GHSR-eGFP was 
not observed in proliferating (Ki67+) cells within the SGZ. These findings suggest a non cell-
autonomous cellular mechanism for acyl-ghrelin mediated AHN, possibly via diffusible 
neurotrophic factors such as BDNF which is known to promote neurogenesis114 and enhance 
pattern separation memory97. It is important to note that Chung et al.115 previously reported 
GHS-R1a expression in these nestin+ stem cells in-vitro, using both western blot and 
immunocytochemistry and acyl-ghrelin enhanced proliferation via ERK1/2 and Akt pathways. 
However, these in-vitro studies were conducted without anti-GHS-R1a antibody validation on 
GHS-R-ko cells or tissues, an important control considering that generating antibodies to 
specific GPCRs is notoriously difficult. We recently confirmed that a GHS-R1a antibody lacked 
specificity using brain tissue from GHS-R-null mice116. Moreover, cell type specific RNA-seq 
data from post-natal mouse brain, including the DG, illustrates the absence of GHS-R 
expression within NSPCs117, supporting our findings obtained in GHSR-eGFP mice11. 
Together, these studies suggest that acyl-ghrelin is acting via a non cell-autonomous 
mechanism to support AHN (figure 4).  
 





Concluding remarks and future perspectives 
   
 
   
 
Together, these findings indicate that the calorie restriction-mediated increase in plasma acyl-
ghrelin with subsequent enhancements in AHN may confer important survival advantages to 
an organism. For example, this gut-derived signal for hunger increases the number of new 
adult-born hippocampal neurones thereby improving discrimination of similar but distinct 
environments. This function would enhance the ability to remember precise locations of 
palatable food, particularly during periods of shortage. Similarly, the enhanced ability to 
distinguish safe vs dangerous environments, as a result of increased neurogenesis and 
enhanced pattern-separation, would improve the chances of successful re-feeding and 
survival. In humans, acyl-ghrelin enhances hippocampal signalling relevant to feeding118,119 
and with recent studies validating the existence of hippocampal neurogenesis that is impaired 
with age and disease81,82 - mimicking observations in experimental animal models – it will be 
important to assess the role of acyl-ghrelin on pattern-separation processes in humans.  
Together, the findings extend our understanding of how adult brain plasticity is regulated by 
endocrine factors of nutritional state and suggest that the ageing brain is acutely sensitive to 
circulating factors such as ghrelin. Next, delineating the underlying mechanisms of ghrelin-
mediated AHN is necessary to develop new potential treatments for age-related cognitive 




1. How does ageing effect acyl-ghrelin mediated-AHN and can acyl-ghrelin restore AHN 
in aged mammals?  
2. Which cellular and molecular mechanism(s) underpin acyl-ghrelin’s pro-neurogenic 
effects? 
3. Are new adult-born hippocampal neurones, generated in response to acyl-ghrelin, 
particularly important to the formation and maintenance of memories relating to feeding 
behaviour? 
4. Does acyl-ghrelin induced AHN mediate the anti-anxiety effect of calorie restriction? 
   
 
   
 
5. Obesity has a negative effect on cognitive performance, is this mediated by a reduction 
in acyl-ghrelin and subsequent drop in neurogenic drive? 
6. Does UAG modulate AHN and memory via an unidentified receptor?  
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